---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-22-038292"
form_type: "8-K"
ticker: "ACHV"
cik: "0000949858"
company_name: "ACHIEVE LIFE SCIENCES, INC."
filed_at: "2022-11-25T23:59:59+00:00"
generated_at: "2026-06-21T13:12:46.273642+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Achieve Life Sciences receives Nasdaq delisting notice for low equity; plans to submit compliance plan

## Summary
- Stockholders' equity as of Sept 30, 2022 was $1.0M, below Nasdaq's $2.5M minimum.
- Nasdaq gave 45 days (until Jan 6, 2023) to submit a plan to regain compliance.
- Company expects to submit plan citing recent private offering to boost equity.
- If plan accepted, Nasdaq may grant up to 180 days extension; if not, delisting possible.
- No immediate effect on trading; stock continues on Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001564590-22-038292
- form_type: 8-K
- ticker: ACHV
- cik: 0000949858
- company_name: ACHIEVE LIFE SCIENCES, INC.
- filed_at: 2022-11-25T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/949858/000156459022038292/0001564590-22-038292-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/949858/000156459022038292/achv-8k_20221122.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-22-038292
- JSON: https://secwatch.observer/filing/0001564590-22-038292.json
- Plain text: https://secwatch.observer/filing/0001564590-22-038292.txt

## Key facts
- Listing & Compliance Notices
  ACHIEVE LIFE SCIENCES, INC. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: stockholders equity
  - Rules: 5550(b)(1)
  source text: November 22, 2022, Achieve Life Sciences, Inc., a Delaware corporation (the “ Company ”), received a written notification from the Listing Qualifications staff of The Nasdaq Stock Market (“ Nasdaq ”) that the Company is not in compliance with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market. Nasdaq Listing Rule 5550(b)(1) requires listed companies to maintain stockholders’ equity of at least $2.5 million (the “ Stockholders’ Equity Requirement ”). The Company’s Form 10-Q for the quarter ended September 30, 2022, filed on November 14, 2022, reflect
  evidence_url: https://www.sec.gov/Archives/edgar/data/949858/000156459022038292/0001564590-22-038292-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.